Low-Dose Captopril for the Treatment of Mild to Moderate Hypertension
In this article, the Veterans Administration Cooperative Study Group reported on their double-blind trial involving the new
antihypertensive agent, captopril, an angiotensin converting enzyme (ACE) inhibitor. Like all ACEs, captopril prevents the
synthesis of angiotensin II, a hormone that usually causes blood vessels to constrict. Although acknowledging the need for
further study, the group determined that captopril appeared to be a very effective antihypertensive agent, especially when
administered in combination with the diuretic hydrochlorothiazide.
Number of Image Pages:
6 (909,259 Bytes)
Veterans Administration Cooperative Study Group on Antihypertensive Agents
Periodical: Veterans Administration Cooperative Study Group on Antihypertensive Agents. "Low-Dose Captopril for the Treatment of Mild
to Moderate Hypertension." Hypertension (Supp. III) 5, 5 ([September-October 1983]): III-139-III-144. Article. 6 Images.
[American Heart Association]
This item is in the public domain. It may be used without permission.
Medical Subject Headings (MeSH):
After 1980: Changing Trends in Hypertension Therapy